Pertussis Therapeutic Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Pertussis Therapeutic Market is segmented By Clinical Stages of Development (Late Stage Products, Mid-Stage Products, Early-Stage Products, By Route of Administration (Oral, Intravenous, Subcutaneous, Parenteral, Topical), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Pertussis Therapeutic Market is segmented By Clinical Stages of Development (Late Stage Products, Mid-Stage Products, Early-Stage Products, By Route o....

Pertussis Therapeutic Market Size

Market Size in USD

CAGR3.4%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	3.4%
Market Concentration	High
Major Players	Tianjin CanSino Biotechnology, ILiAD Biotechnologies, GlaxoSmithKline (GSK), Sanofi, AstraZeneca

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Pertussis Therapeutic Market Analysis

The pertussis therapeutic market is estimated to be valued at USD 3.8 Bn in 2024 and is expected to reach USD 4.8 Bn by 2031, growing at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031. The market has been witnessing steady growth over the past few years driven by high prevalence of pertussis across the globe.

Pertussis Therapeutic Market Report Snapshots

Buy Now